Should I Buy GOCO? GOCO 2026 Analysis

Should You Buy Gohealth Inc (GOCO) Today? Analysis, Price Targets, and 2026 Outlook.

No data

Growth

Profitability

Efficiency

3 Analyst Rating

Wall Street analysts forecast GOCO stock price to rise

1 Buy

2 Hold

0 Sell

Moderate Buy

Current: 0.702

Low

Averages

7.5

High

Current: 0.702

Low

Averages

7.5

High

Freedom Broker

Buy

Hold

downgrade

AI Analysis

2026-04-06

Reason

Freedom Broker

Price Target

AI Analysis

2026-04-06

downgrade

Buy

Hold

Reason

Freedom Broker downgraded GoHealth to Hold from Buy with a price target of $1.50, down from $4.50. The company's Q4 revenue dropped 97% year-over-year amid deterioration in Medicare Advantage commission economics, the analyst tells investors in a research note. The firm sees a "weak" 2026 for GoHealth and is "cautious" on a rebound in 2027.

RBC Capital

Sector Perform

downgrade

$12 -> $5

2025-11-26

Reason

RBC Capital

Price Target

$12 -> $5

2025-11-26

downgrade

Sector Perform

Reason

RBC Capital lowered the firm's price target on GoHealth to $5 from $12 and keeps a Sector Perform rating on the shares. The firm is updating its model following the company's Q3 results, which came in significantly below expectations due to topline weakness as a result of one large carrier suspending its relationship with, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for GOCO

Unlock Now

GOCO Should I Buy

GOCO Should I Buy

Should You Buy Gohealth Inc (GOCO) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

Growth

Profitability

Efficiency

People Also Watch